A Phase III Study of Anti-B4-Blocked Ricin as Adjuvant Therapy Post-Autologous Bone Marrow Transplant: CALGB 9254
Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2010.543714
Full Text
Open PDFAbstract
Available in full text
Date
January 28, 2011
Authors
Publisher
Informa UK Limited